ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
CRISPR Therapeutics
The Senior Manager, Program Management will drive the success of R&D development teams by managing and integrating diverse drug development activities across discovery, preclinical research, CMC, regulatory affairs, and clinical development. This role requires a confident program manager with a proven track record in preclinical and early clinical stage program management for therapeutic programs in the biotechnology industry. The ideal candidate will possess a solid scientific understanding of genome editing technologies and cell and gene therapy development.
Headquarters
Boston, Massachusetts, United States
Company Size
201-500 employees
Founded
2013
CRISPR Therapeutics is a gene-editing company pioneering the development of transformative medicines using CRISPR/Cas9 technology to treat serious diseases. The company has a broad pipeline spanning hemoglobinopathies, immuno-oncology, autoimmune diseases, in vivo editing, and regenerative medicine, including CASGEVY™, the first-ever approved CRISPR-based therapy for sickle cell disease and transfusion-dependent beta thalassemia. CRISPR Therapeutics operates across multiple clinical and preclinical programs in collaboration with partners such as Vertex Pharmaceuticals.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CRISPR Therapeutics.
CRISPR Therapeutics’ CASGEVY Progress Reframes Growth And Valuation Story
2 days ago
Sr. Scientist, Gene Therapy and Gene Editing
AskBio
R&D Manager Leadership Development Program, Solid Tumor
Legend Biotech
Director, International CMC Regulatory Affairs – Cell and Gene Therapy
AstraZeneca
Co-op: Off-Target Analysis of Gene Editing
Prime Medicine
Physician-Scientist, Hemoglobinopathies Research Group
Vertex
Scientific Leader, Potency and Functional Bioassay Development
AstraZeneca
